Amicus Therapeutics, Inc. (FRA:AM6)
12.00
0.00 (0.00%)
Last updated: Jan 6, 2026, 8:03 AM CET
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
€1,022,596
Profits / Employee
€24,016
Market Cap
3.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 499 | -18 | -3.48% |
| Dec 31, 2023 | 517 | 33 | 6.82% |
| Dec 31, 2022 | 484 | -12 | -2.42% |
| Dec 31, 2021 | 496 | 13 | 2.69% |
| Dec 31, 2020 | 483 | -101 | -17.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Amicus Therapeutics News
- 13 days ago - Noteworthy ETF Inflows: XBI, FOLD, MRNA, EXEL - Nasdaq
- 16 days ago - Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD - Business Wire
- 17 days ago - BioMarin Pharmaceutical Inc. (BMRN) Amicus Therapeutics, Inc., - M&A Call - Slideshow - Seeking Alpha
- 18 days ago - Is the Market Bullish or Bearish on Amicus Therapeutics Inc? - Benzinga
- 19 days ago - What's Going On With BioMarin Stock On Tuesday? - Benzinga
- 20 days ago - BioMarin: Amicus Buyout Sparks My Enthusiasm - Seeking Alpha
- 20 days ago - Amicus Therapeutics (FOLD) Sees Analyst Rating Downgrade from Citigroup | FOLD Stock News - GuruFocus
- 23 days ago - BioMarin Stock Surges Nearly 20% After $4.8 Bln Amicus Acquisition News - Nasdaq